肺纤方加减治疗36例特发性肺纤维化患者CT积分改变及生活质量影响  被引量:19

Effects of changes of CT scores and quality of life in 36 patients with idiopathic pulmonary fibrosis treated by modified Feixian Fang

在线阅读下载全文

作  者:王紫娟[1] 张宇婷[1] 顾潇枫 于小林[1] 孟丽红 刘彧杉 张晓梅[2] WANG Zi-juan;ZHANG Yu-ting;GU Xiao-feng;YU Xiao-lin;MENG Li-hong;LIU Yu-shan;ZHANG Xiao-mei(Beijing University of Chinese Medicine,Beijing 100029,China;Dongfang Hospital Affiliated to Beijing University of Chinese Medicine,Beijing 100078,China)

机构地区:[1]北京中医药大学,北京100029 [2]北京中医药大学东方医院,北京100078

出  处:《中华中医药杂志》2018年第8期3682-3685,共4页China Journal of Traditional Chinese Medicine and Pharmacy

基  金:国家自然科学基金项目(No.81273696)~~

摘  要:目的:观察肺纤方对特发性肺纤维化(IPF)患者胸部CT积分变化的影响。方法:给予36例IPF患者肺纤方加减口服,方中冬虫夏草使用冬虫夏草菌丝粉胶囊(百令胶囊)代替,每次4粒,配合中药口服,每日2次。观察治疗前后患者CT积分及生活质量的变化。结果:治疗后患者CT积分较治疗前下降,网格影、蜂窝影变化明显(P<0.05);患者生活质量得到一定改善。结论:肺纤方在一定程度上能改善肺肾亏虚,痰瘀阻络证患者的临床症状及体征,减轻患者影像改变,改善患者肺功能,提高其活动耐力及生活质量。Objective: To observe the effect of Feixian Fang (FXF) on the changes of chest CT scores and quality of life in idiopathic pulmonary fibrosis(IPF) patients with lung-kidney deficiency syndrome and syndrome of phlegm and blood stasis. Methods: Patients were given oral FXF, where Chinese caterpillar fungus was replaced with Cordyceps Sinensis Powder Capsule (Bailing capsule), 4 capsules each time, twice daily. The CT scores and the quality of life were observed before and after treatment. Results: The CT scores were lower than that before treatment, significant changes were found in reticular pattern and honeycombing (P〈0.05). And the quality of life was improved. Conclusion: Clinical observation showed that FXF can significantly improve clinical symptoms and signs of patients with lung-kidney deficiency syndrome and syndrome of phlegm and blood stasis, reduce image changes, improve lung function, activity tolerance and quality of life.

关 键 词:肺纤维化 肺纤方 CT积分 临床观察 

分 类 号:R259[医药卫生—中西医结合]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象